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The pseudorabies virus protein, pUL56, enhances virus 
dissemination and virulence but is dispensable for axonal 
transport
Gina R. Daniela, Patricia J. Sollarsb, Gary E. Pickardb, and Gregory A. Smitha,*
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bSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, 
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Abstract
Neurotropic herpesviruses exit the peripheral nervous system and return to exposed body surfaces 
following reactivation from latency. The pUS9 protein is a critical viral effector of the anterograde 
axonal transport that underlies this process. We recently reported that while pUS9 increases the 
frequency of sorting of newly assembled pseudorabies virus particles to axons from the neural 
soma during egress, subsequent axonal transport of individual virus particles occurs with wild-
type kinetics in the absence of the protein. Here, we examine the role of a related pseudorabies 
virus protein, pUL56, during neuronal infection. The findings indicate that pUL56 is a virulence 
factor that supports virus dissemination in vivo, yet along with pUS9, is dispensable for axonal 
transport.
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Introduction
The herpesviridae are a diverse family of viruses that share a core set of conserved 
properties [1, 2]. Their common morphology consists of a double-stranded linear DNA 
genome housed in an T=16 icosahedral capsid, surrounded by a proteinaceous tegument 
layer and membrane envelope [3]. Infections by these viruses alternate between productive 
and latent states, although tissue tropism and the site of latency vary across herpesviridae 
subfamilies and genera. For members of the simplexvirus and varicellovirus genera of the 
alphaherpesvirinae subfamily, latency occurs in ganglia of the peripheral nervous system 
(PNS). Periodic reactivation from the latent state results in nascent particle assembly and 
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subsequent transmission back to body surfaces, where virus shedding can be accompanied 
by mucosal or skin lesions. In rare events, infections can result in life-threatening 
encephalitic disease.
The transmission of viral particles outward from sensory ganglia following a reactivation 
event is termed anterograde axonal transport, which occurs following the induction of viral 
gene expression and virion assembly. Newly assembled virus particles are sorted within the 
cytoplasm of the neuron from the soma to the axon, and are then transported along 
microtubules to the distal axon terminals where the virus subsequently spreads to the 
innervated tissue [4, 5]. Studies of pseudorabies virus (PRV; a highly neurovirulent 
varicellovirus that infects a broad range of veterinary hosts, and serves as a model for 
encephalitic disease) and herpes simplex virus type 1 (HSV-1; a rarely neurovirulent 
simplexvirus that causes herpes labialis in humans) indicate that fully assembled virus 
particles are transported anterogradely in host vesicles [6–21]. A viral type-II 
transmembrane protein that is resident in the transport vesicle membrane, pUS9, serves as an 
effector of anterograde axonal transport for PRV and HSV-1 by augmenting the cytoplasmic 
sorting of viral particles into axons from the neuronal cell body [8, 22–26]. Following 
sorting, pUS9 remains associated with viral particles [27], but is nevertheless dispensable 
for the subsequent microtubule-based anterograde transport that occurs within axons [28].
The magnitude of the anterograde-deficit displayed by recombinant viruses lacking pUS9 
depends on the infection model. PRV does not reach visual centers of the brain by 
anterograde transport from the rat retina in the absence of pUS9 [28, 29], whereas HSV-1 
lacking pUS9 spreads in the same circuit within a mouse host, but at reduced levels [30]. 
Yet the PRV deficit is also not absolute, as PRV lacking pUS9 spreads anterogradely 
between nuclei within the brain [29, 31]. These findings suggest that additional viral 
proteins promote transport independently of pUS9. In this report, we examine the 
contribution of pUL56, which like pUS9 is a type-II transmembrane protein that is proposed 
as a candidate transport effector [32–34]. PRV strains lacking pUS9, pUL56, or both 
proteins were examined in cultures of primary sensory neurons and in animals. Our findings 
indicate that in PRV, pUL56 contributes to spread and virulence in animals, but unlike 
pUS9, does not contribute to axonal sorting. Furthermore, pUL56 and pUS9 provide no 
measurable contribution to the process of microtubule-based anterograde transport within 
axons.
Materials and Methods
Plasmid Construction
Recombinant PRV strains used in this study were constructed with two-step RED-mediated 
recombination using a pBecker3 infectious clone, GS4284, previously made to express a 
pUL25/mCherry capsid fusion [35–37]. To delete the UL56/ORF1.2 locus, the following 
primer pair was made with 5′ homologies flanking the ORF1.2 coding sequence to be 
deleted and 3′ homologies (underlined) to pEPkan-S2 [38]: 5′ 
CGCAGGTCCTGCGGGCGTACCAGATCGGTTGATGTGCGAACGATGTGACCAATA
AACTCGAGGATGACGACGATAAGTAGGG and 5′ 
GAGACGCGGATATCGATAGGACTGGCGAGCCGAGTTTATTGGTCACATCGTTCG
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CACATCCAACCAATTAACCAATTCTGATTAG. The PCR product was recombined into 
infectious clone GS4284 and GS5469, the latter of which is a derivative of GS4284 deleted 
for the US9 gene [28]. Two-step recombination resulted in infectious clones GS4673 and 
GS5658 (Table 1). The deletion of ORF1.2 removed all codons following the start ATG, and 
preserved the stop codon and 3′ untranslated region. This deletion also removed the smaller 
UL56 coding sequence, which is embedded in and co-terminal with ORF1.2. The deletion 
was separated from the polyadenylation sequence of the downstream UL54 antisense 
transcript by 145 nt. Mutant viruses were initially identified by restriction enzyme analysis 
and confirmed by sequencing.
Cells and Viruses
PK15 cells were maintained in 10% bovine growth supplement (BGS; HyClone). During 
infection, the BGS concentration was reduced to 2%. Infectious clones were transfected into 
PK15 cells as previously described to produce stocks of recombinant PRV [39]. Working 
stocks were made by an additional passage through PK15 cells. Virus stocks were titered on 
PK15 cells as previously described [40]. Titer measurements were compiled from ≥ 3 
individual working stocks. The diameters of greater than 40 plaques on PK15 cells were 
measured for each virus based on red capsid fluorescence emissions, and this was then 
repeated a total of three times for each virus. Final measurements were normalized as a 
percent of the parental virus plaque diameter. Single-step growth kinetics were determined 
as previously described [41].
Neuronal Culture
Sensory neurons were isolated from the dorsal root ganglion (DRG) of embryonic (E8–E10) 
chicks and cultured as previously described as either whole explants or disassociated cells 
[5, 42]. DRG neurons were cultured onto 22 mm2 No. 1.5 glass coverslips treated with poly-
DL-ornithine (PO). Laminin was added as a second substrate for whole explant cultures. 
Neuron cultures were maintained for 2–3 days with partial media change on day 2, and then 
infected with recombinant PRV isolates. Infections were conducted in a 2 ml volume in a 
well of a 6-well tissue culture tray (one coverslip per well). Explants were infected with 7–
8×107 PFU/ml and imaged during the first hour post-infection. This provided large numbers 
of retrograde transport events for analysis. In contrast, dissociated neurons were infected 
with 2–3×106 PFU/ml and imaged for egress (anterograde transport) events from 10–13 hpi 
as previously described [7]. While this protocol limited the number of egress events that 
were captured, the low density of plated neurons allowed for unambiguous assessment of 
transport direction (anterograde vs retrograde), which is necessary during late time points 
when egress from primary infected neurons can be confounded by retrograde transport 
events following entry into a second round of cells.
Fluorescence Microscopy and Image Analysis
Virus particles were tracked in axons as described previously [43]. For virus transport 
experiments in dissociated or explant DRGs, imaging was done on a Nikon Eclipse TE2000-
U wide-field fluorescence microscope with a 100×1.49 numerical aperture (NA) objective 
and a Cascade II:512 camera. Emissions from mCherry were acquired using 100-ms 
streaming exposures. The velocities and run lengths of virus particles moving greater than 
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0.5 μm were measured with the Kymograph function in the MetaMorph software package. 
The ΔUL56 transport data sets presented here were conducted concurrently with a parental 
and ΔUS9 transport analysis that was previously published and included here for direct 
comparison [28]. Measurement of particle flux was performed by counting the number of 
capsids that passed through a defined position along the axon that was demarcated by a 5 μm 
perpendicular reference line, during a 30 s period.
Viral particle accumulation in axons were imaged by virtue of the mCherry-capsid reporter 
fusion using 1 s exposures on an inverted wide-field Nikon Eclipse TE2000-E fluorescence 
microscope fitted with a 60×1.4 NA objective and a Photometrics CoolSnap HQ2 camera. 
Experiments were repeated in triplicate. Viral particle accumulation along the length of 
axons was enumerated in axons whose lengths were greater than 100 μm and were as long as 
450 μm; axons shorter than one field of view (100 μm) were excluded from the count. All 
counts were determined manually. In regions with dense capsid accumulation, counts were 
likely underestimates since images were taken in a single focal plane and capsids coincident 
with each other were only scored as a single particle. At least 6 neurons per sample were 
counted for the 3 hpi time point, and ≥ 20 neurons per sample were counted in total for the 
15–18 hpi time point across 2 experiments. Fluorescent plaque diameters were measured 
with a 10x objective and 100 ms exposures.
Animal Studies
The use of animals in this study was approved by the University of Nebraska-Lincoln 
Institutional Animal Care and Use Committee. CD-1 mouse infection: Male mice (received 
from Charles River at 6 weeks of age) were acclimated to a 12:12 light:dark cycle for at 
least 2 weeks prior to infection. When 8–15 weeks old, animals were infected intranasally 
with 8–9×105 PFU/nostril (in a 5 μl volume/nostril) of PRV under 2.5% isofluorane 
inhalation anesthesia, as previously described [36]. Five animals were monitored per virus to 
determine mean time of death (MTD). A one-way ANOVA with Tukey post-test were used 
to determine significance. Long-Evans rat infection: Male rats (received from Charles River 
at 8 weeks of age) were acclimated to a 12:12 light:dark cycle for at least 2 weeks prior to 
infection. When 10–16 weeks old, animals were infected with PRV under 2.5% isofluorane 
inhalation anesthesia by unilaterally injecting either 10 μl of a ≅ 1×108 PFU/ml stock into 
the vitreous humor of the eye or 2 μl of the same stock into the anterior chamber of the eye, 
as previously described [44]. Animals were sacrificed at the indicated times by transcardial 
perfusion with 0.9% saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer 
(PB). The brain and the superior cervical ganglion (SCG) ipsilateral to the injected eye were 
removed, post-fixed overnight at 4 C in 4% paraformaldehyde in PB with 20% sucrose. 
Tissue was sectioned at 30 μm on a Leica cryostat, mounted on slides, coverslipped with 
Vectashield and examined using a Leica DM5500 B fluorescence microscope fitted with a 
Hamamatsu CCD ORCA-flash 4.0 digital camera.
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Results
Initial characterization of mutant viruses
To assess the contribution of pUL56 toward neuronal infection, PRV deleted for the UL56 
gene was derived from a pBecker3 infectious clone encoding a pUL25/mCherry fluorescent 
capsid tag. The capsid tag allows for imaging of individual viral particles in living cells [35, 
36, 38]. The deletion removed the entire UL56 coding sequence and further encompassed an 
extended sequence referred to as ORF 1.2: a putative coding region that is in-frame and co-
terminal with UL56 [45]. The resulting deletion virus, PRV-GS4673, is referred to as the 
ΔUL56 virus in this report (Table 1). The ΔUS9 mutant, PRV-GS5469, has the second 
codon through the last in-frame ATG replaced with a stop codon, and was previously 
described [28]. The ΔUL56 and ΔUS9 viruses remained fully competent to spread in PK15 
epithelial cells (Fig. 1A) and propagated to titers equivalent to the parental strain (Fig. 1B) 
with normal kinetics (Fig. 1C). Consistent with prior reports, these findings document that 
neither pUS9 nor pUL56 significantly contribute to productive infection in non-neuronal cell 
culture [29, 46], and further indicate the UL56 deletion did not result in polar effects on the 
downstream antisense transcripts for UL52 (helicase/primase), UL53 (gK) and UL54 
(ICP27), which share a poly-adenylation signal that is 145 nt downstream of the UL56 
deletion [47].
Retrograde axonal transport in culture
Membrane proteins are not expected to contribute to the initial seeding of neurons by 
retrograde axonal transport, as this process occurs after the virion envelope is removed 
following fusion-based entry into axons [48]. Nevertheless, retrograde axonal trafficking 
was monitored to confirm that deletion of UL56 did not impair this early stage of neuronal 
infection [42]. Dorsal root ganglia (DRG) explants of sensory neurons were infected with 
either the parental fluorescent PRV strain or its ΔUL56 derivative (these experiments were 
conducted concurrently with the previously described ΔUS9 mutant [28]). The motion of 
incoming fluorescent capsids was tracked during the first hour post-infection to determine 
velocities and run lengths of individual viral particles, and the frequency of transport events 
(flux). Based on this analysis, deletion of UL56 did not perturb retrograde transport of viral 
particles (Fig. 2, upper panels).
Anterograde axonal transport in culture
Following replication, newly-assembled PRV particles traffic from the soma of the neuron 
to the axon. To obtain an accounting of viral particle sorting into axons, disassociated DRG 
sensory neurons were plated sparsely to limit axon interactions, and infected two days post-
culturing. The number of virus particles along the length of the axon in an infected neuron, 
including the terminal, was enumerated at both 3 hpi (prior to the onset of anterograde 
axonal transport) and from 15–18 hpi [5, 7]. Unlike the sorting defect exhibited by the ΔUS9 
mutant, the ΔUL56 virus produced particles that sorted into axons as efficiently as the 
parental strain (Fig. 3A). Furthermore, the ΔUL56 particles accumulated at the terminals of 
the axons by 15–18 hpi, providing an initial indication that microtubule transport within 
axons occurred normally (Fig. 3B–C).
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To examine the intra-axonal transport phenotype of the ΔUL56 virus more closely, 
individual virus particles moving in axons were recorded by time-lapse imaging and the 
kinetics of transport were measured. The ΔUL56 mutants transported in the anterograde 
direction in axons like the parental strain in terms of velocity, run length, and flux (Fig. 2, 
lower panels). A similar result was observed in experiments conducted in parallel with the 
ΔUS9 mutant [28]. Because pUS9 and pUL56 are both type-II structural membrane proteins 
[22, 32], a ΔUL56/ΔUS9 double-mutant virus encoding the pUL25/mCherry capsid tag 
(PRV-GS5658) was made to determine if the proteins possessed redundant function (Table 
1). The ΔUL56/ΔUS9 virus produced plaque sizes and titers on PK15 epithelial cells 
equivalent to the individual mutants and the parental strain (Figure 1A, B). Like the ΔUS9 
and ΔUL56 viruses, the ΔUL56/ΔUS9 recombinant remained competent for anterograde 
axonal transport, indicating that the engagement of kinesin motors that move PRV 
anterograde in axons occurs by a mechanism that is independent of these type-II membrane 
proteins (supplemental movie).
Virulence and dissemination in the nervous system
CD-1 mice were infected intranasally with the parental or mutant PRV strains encoding the 
pUL25/mCherry fusion, and the mean survival times were determined [49]. Infection with 
the parental PRV resulted in a mean survival time of 56.4 hours, consistent with a prior 
study [36]. Infection with the ΔUL56, ΔUS9, or ΔUL56/ΔUS9 virus extended mean survival 
times significantly, indicating that both pUL56 and pUS9 are required for full virulence in 
this model (Fig. 4).
To determine the degree to which the parental and mutant viruses could infect circuits via 
anterograde axonal transport, Long-Evans rats were infected in the vitreous humor of the 
eye to initiate an infection in the retinal ganglion neurons that project axons to the visual 
centers of the brain. This is the model traditionally used to discern transneuronal anterograde 
transmission defects of PRV in the mammalian nervous system, a model for which PRV 
requires pUS9 [25, 28, 29, 50–53]. At 48 hpi, the animals were sacrificed, and tissue 
sections from the eye or the retinorecipient visual centers of the brain were prepared. 
Infected cells were identified based on the presence of intranuclear fluorescence from newly 
assembled capsids containing the pUL25/mCherry tag. The transmission of the ΔUL56 virus 
to visual centers was equivalent to the parental strain, indicating that pUL56 is not required 
for transneuronal spread following anterograde axonal transport in the mammalian nervous 
system (Fig. 5). This result extends the anterograde trafficking results obtained in cultured 
sensory neurons (Figs. 2 & 3), but does not account for the virulence defect of the ΔUL56 
mutant observed in mice (Fig. 4). Therefore, we next examined the neuroinvasive property 
of the ΔUL56 mutant in a retrograde circuit.
Long-Evans rats were infected by injecting either the parental, ΔUL56, ΔUS9, or the 
ΔUL56/ΔUS9 virus into the anterior chamber of the eye. In this model, viral replication 
initially occurs in the iris and ciliary body, which precedes entry into axons innervating 
these tissues and retrograde axonal transport to peripheral ganglia, including the superior 
cervical ganglion (SCG) [43]. The rat SCG contains ≅ 30,000 neurons, of which 600–1000 
project directly to the eye [54]. At the indicated times, animals were sacrificed, 
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transcardially perfused, and the SCG ipsilateral to the injected eye was removed and 
prepared for microscopic examination. Infection with the parental virus resulted in labeling 
of > 5000 neurons in the SCG, indicating infection had surpassed the initial seeding of the 
ganglion. In contrast, although the ΔUS9 and ΔUL56/ΔUS9 viruses seeded the SCG, the 
number of infected neurons did not surpass the number of neurons that project to the eye, 
consistent with these infections being restricted to neurons that innervated the eye directly. 
This may be explained by the reduced capacity of the ΔUS9 viruses to engage in anterograde 
axonal transport, which should effectively imprison the virus in the initially seeded SCG 
neurons. Although the ΔUL56 mutant did not share the ΔUS9 sorting defect, it presented an 
intermediate defect in the number of neurons infected in the SCG, indicating that pUL56 
enhances infection of the peripheral nervous system (Fig. 6).
Discussion
To transmit between hosts, a latent neuroinvasive herpesvirus infection must reactivate and 
send newly-assembled viral particles from peripheral sensory ganglia to body surfaces by 
anterograde axonal transport. The same process can, in rare instances, result in transmission 
of infection from sensory neurons to the central nervous system (CNS), resulting in life-
threatening encephalitic disease [55]. Because reactivation from latency is normally sporadic 
and of varying magnitude, anterograde axonal transport is typically studied in models of 
acute infection. Thus, in a CNS invasive model of infection based on inoculating PRV in the 
vitreous chamber of the rat eye, virus infects local neurons in the retina (retinal ganglion 
cells) and then transmits within these neurons to the brain by anterograde axonal transport. 
For PRV, the pUS9 type-II membrane protein is often referred to as an essential determinant 
for anterograde axonal transmission because ΔUS9 mutants of PRV fail to spread to the 
brain in this rat eye model [29]. However, pUS9 is not essential in all contexts. For example, 
in an intracranial model of CNS infection, pUS9 is dispensable for anterograde axonal 
transport between distal nuclei within the brain [29].
Anterograde axonal transport consists of two steps. First, nascent cytoplasmic viral particles 
are sorted from the cell body into the axon. Once in the axon, the particles transport to the 
terminal by plus-end directed microtubule transport. The latter is sustained over distances of 
several centimeters to nearly a meter [56]. In the absence of pUS9, the initial step of PRV 
sorting into axons occurs infrequently [27]; however, the few PRV particles that transport in 
the absence of pUS9 do so with kinetics that are indistinguishable from PRV encoding pUS9 
[28]. Because ΔUS9 PRV can sustain long-distance transport within axons to spread 
anterogradely in the intracranial model and in cultured primary neurons, this indicates that 
additional effectors of axonal transport may exist [8, 28, 29].
A second type-II transmembrane protein, pUL56, was suggested to have transport effector 
functions based on studies of HSV-2 [32, 33, 57]. Although pUL56 was described initially 
in HSV, phylogenetic studies have identified a UL56 ortholog in PRV, previously called 
ORF-1 [58]. We chose to delete ORF-1/UL56 along with the an overlapping and co-terminal 
coding sequence called ORF1.2, to effectively rule out either as encoding effectors of axonal 
transport. Deletion of UL56 and ORF1.2 from PRV did not impair viral replication in 
epithelial cells, in agreement with previous reports [46]. The retrograde axonal transport 
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kinetics of the mutant were equivalent to the parental strain following entry into primary 
cultured neurons and the kinetics were also unperturbed for anterograde transport during 
neuronal egress, with the latter culminating in normal accumulation of PRV particles at axon 
terminals. These findings were consistent with the subsequent studies in animals, where the 
mutant was not impaired for infection of visual centers of the rat brain via anterograde 
transport from the eye. We conclude that pUL56 (and products from ORF1.2) is not an 
effector of PRV anterograde transport in primary cultured neurons or in vivo. Unlike pUS9, 
pUL56 did not promote initial sorting of cytoplasmic PRV particles into axons, and neither 
pUS9 nor pUL56 (deleted individually or together) were required for intra-axonal transport 
of particles beyond the sorting barrier.
Whether other viral effectors of kinesin-based anterograde trafficking encoded by PRV 
contribute to post-sorting anterograde axonal transport remains an open question. Because 
PRV transports anterogradely as a fully-assembled virus particle within the lumen of a 
transport vesicle, there may be no need for a virally-encoded transport effector during this 
stage of infection if the vesicle is targeted to the axon terminal by the cell. However, there 
are reports that in addition to vesicle-based anterograde transport, HSV-1 may uniquely be 
able to transport as a proteinaceous capsid/tegument particle directly in the cytosol of the 
axon [4, 21]. In this scenario, HSV-1 would require a direct effector of kinesin recruitment. 
In either scenario, the pUL36 large tegument protein is an interesting candidate effector 
based on its role in kinesin-based transport of capsids in vitro [59].
Whereas deletion of UL56 had no impact on anterograde transport in vivo, infection of 
peripheral ganglia, a retrograde circuit, was attenuated. This reduction in infection was not 
accounted for in the culture studies where defects in propagation, spread, and axonal 
transport were not observed. Nevertheless, the defect corresponded to reduced virulence; in 
fact, in the mouse intranasal model, ΔUL56 infection was more attenuated than infection by 
the ΔUS9 virus. pUL56 has multiple reported functions in related alphaherpesviruses, 
including modulation of cell-surface markers, regulation of cellular ubiquitin ligases, and 
interaction with viral proteins that ultimately interact with glycoprotein E [57, 60–68]. These 
interactions could promote innate immune evasion in the host. Further studies will be 
needed to identify the mechanism by which pUL56, and possibly products of ORF1.2, 
contributes to virulence.
Supplementary Material
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• pUL56 and pUS9 type-II membrane proteins are encoded by neuroinvasive 
herpesviruses
• pUL56 and pUS9 are virulence factors that enhance seeding of the nervous 
system
• Unlike pUS9, pUL56 does not contribute to sorting of virus into axons
• Intra-axonal transport of PRV particles occurs independently of both proteins
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Figure 1. Deletion of UL56 or US9 from PRV does not impair replication in the PK15 epithelial 
cell line
Plaque diameters (A) and titers (B) were measured on PK15 cells after infection with the 
parent PRV strain or derivatives lacking UL56 or US9, singly or in combination. (A) 
Greater than 40 plaques were measured per experiment and experiments were repeated in 
triplicate (error bars indicate standard deviation). (B) Titer measurements were compiled 
from three or more viral stocks (error bars indicate standard error of the mean). (C) Single-
step replication kinetics of parental, ΔUL56, or ΔUS9 infection was determined by 
collecting infected cells or infected cell supernatants at the indicated times, followed by 
plaque assay to determine titer.
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Figure 2. Deletion of UL56 from PRV does not alter retrograde or anterograde transport 
dynamics of viral particles in culture
Primary sensory neurons were infected with the parental strain or ΔUL56 PRV and pUL25/
mCherry capsids were imaged during ingress from 15–60 min post infection (upper panels) 
and during egress from 10–13 hpi (lower panels). Viral particles moving in axons greater 
than 0.5 μm were tracked and individual velocities and run lengths were measured during 
ingress (parent, n=288; ΔUL56, n=175) and egress (parent, n=38; ΔUL56, n=48). Gaussian 
(velocities) or decaying exponential (run lengths) curves were fit to histograms by non-
linear regression; for all experiments, curve-fitting produced R2 values > 0.96. Insets show 
average velocity (left panels) and run length (middle panels); error bars indicate standard 
error of the mean. The frequency of capsid axonal transport events (flux) was measured as 
the number of capsids moving per axon over a 30 s period during ingress (parent, n=99; 
ΔUL56, n=70) and egress (parent, n=21; ΔUL56, n=37) (right panels); error bars indicate 
standard deviation.
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Figure 3. Deletion of US9, but not UL56, results in diminished accumulation of viral particles at 
axon terminals late in infection
(A) Sparsely seeded dissociated primary sensory neurons were infected with parental, 
ΔUL56, or ΔUS9 PRV, and the number of fluorescent capsids localized along the length of 
individual axons were counted at 3 hpi and 15–18 hpi. Only infected neurons extending 
axons > 100 μm that could be traced for their entire length were included in the analysis. 
Error bars indicate standard deviation. Significance was determined with one-way ANOVA 
and Tukey’s post-test. (B) Primary sensory neurons were infected with parental, ΔUL56, 
ΔUS9, or ΔUL56/ΔUS9 virus and the distal ends of the neurons were imaged between 15–18 
hpi. (C) The abundance of viral particles at axon terminals is reported as a frequency based 
on the number of capsids observed per terminal (parent, n=213; ΔUL56, n=45; ΔUS9, 
n=109; ΔUL56/ΔUS9, n=236).
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Figure 4. Contributions of pUS9 and pUL56 to PRV virulence
Five CD-1 mice were infected by intranasal instillation with each virus, and mean survival 
times were determined. A one-way ANOVA with Tukey post-test was used to determine 
significance.
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Figure 5. pUL56 is dispensable for anterograde spread of PRV in rat visual circuits
Long Evans rats were infected by intravitreal injection with parental, ΔUL56, or ΔUS9 PRV. 
The location of the injection in the eye is indicated by an asterisk (*). At 48 hpi, the animals 
were sacrificed. Peripheral tissue sections of the eye, including retinal ganglion cells (RGC), 
or brain sections of retinorecipient visual centers, including the lateral geniculate nucleus 
(LGN) and superior colliculus (SC), were examined for infected neurons, indicated by red-
fluorescence emissions from the pUL25/mCherry capsid fusion. For each infection, three 
animals were examined. A (+) indicates the presence of red-fluorescent/infected cells.
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Figure 6. pUL56 promotes infection of the superior cervical ganglion
Parental, ΔUL56, ΔUS9, or a ΔUL56/ΔUS9 double-mutant virus was injected into the 
anterior chamber of the eye of male Long Evans rats. The location of the injection in the eye 
is indicated by an asterisk (*). Animals were sacrificed at the indicated times and the 
superior cervical ganglion (SCG) was removed, sectioned, and scored for infected neurons 
based on red-fluorescence emissions from the pUL25/mCherry capsid fusion. The symbol 
‘†’ denotes the time of imminent death from infection. The lower dashed line indicates the 
number of neurons in the SCG that project directly to the eye. The upper dashed line 
indicates the total number of neurons, ≅ 30,000, that comprise the SCG.
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Table 1
Viruses used in this study
Virus Reporter Tag Mutation Moniker Source
PRV-GS4284 pUL25/mCherry - parent Bohannon, 2012
PRV-GS4673 pUL25/mCherry ΔUL56 ΔORF1.2 ΔUL56 this study
PRV-GS5469 pUL25/mCherry ΔUS9 ΔUS9 Daniel, 2015
PRV-GS5658 pUL25/mCherry ΔUL56 ΔORF1.2 ΔUS9 ΔUL56/ΔUS9 this study
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